Private Equity Profile
In the last 3 years, SHS has acquired 1 company. It has also invested in 4 others.
SHS’s most common sectors for investment are medical products (52%) and life science (32%). The Firm’s most common investment types include growth capital (60%) and buyout (lbo, mbo, mbi) (20%). In total, SHS has invested in 5 different countries.
In the last 3 years, SHS has exited 4 companies. The Firm’s most common exit type is trade sale (58%). SHS’s largest (disclosed) exit occurred in 2010 when it sold ProBioGen AG for $34M.
Join Mergr to view SHS’s full profile and discover more small private equity firms just like it.
M&A Total Activity32
- M&A Buy Activity25
- M&A Sell Activity7
- Total Sectors Invested 5
- Total Countries Invested 5
- M&A Buy/Sell Connections 5